Monday, September 15, 2025 9/15/2025

Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections

Award Number: R01AI173686
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/11/2023
PERIOD OF PERFORMANCE END DATE: 06/30/2027

Group Awards By:

View Award Description

Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections - Project Summary/Abstract The spread of antibiotic resistance is a growing concern as the emergence of resistance mechanisms among human pathogens is occurring more rapidly than the development of new antimicrobial agents. This issue contributes to the inability to fully clear persistent infections such as chronic wound and lung infections, which represent a major source of human morbidity and mortality. In turn, the inability to eradicate these persistent infections creates more opportunities for the evolution of novel microbial mechanisms to circumvent therapeutic treatment, exacerbating the problem of antibiotic resistance. There are multiple aspects of the chronic infection environment that contribute to therapeutic failure and the emergence of antibiotic resistance. First, several stressors encountered at the host-pathogen interface are mutagenic, which helps drive evolutionary adaptation in these sites. Second, the polymicrobial nature of many chronic infections can contribute to the spread of resistance mechanisms via horizontal gene transfer. The presence of polymicrobial communities can also further compound the issue of therapeutic clearance of infection since interspecies microbial interactions are known to alter bacterial physiological and lead to antimicrobial tolerance. In this proposal, we seek to target both the microbial evolutionary trajectory at the host-pathogen interface and the polymicrobial nature of chronic infections to design improved therapeutic strategies for eradication of pathogens contributing to otherwise persistent infections. In Aim 1, we propose to target antibiotic resistant isolates through the identification of vulnerability tradeoffs that can occur as the cell shifts its fundamental physiology to cope with antibiotic exposure. In addition to published examples of this phenomenon, we demonstrate our ability to uncover novel examples of tradeoffs that can be exploited to eradicate otherwise recalcitrant microorganisms. We seek to uncover more examples of vulnerability tradeoffs and determine the effectiveness of targeting these tradeoffs in a murine model of chronic wound infection. In Aim 2, we establish polymicrobial community wound pathogen models and use a methodology that we propose can be adapted for use in the clinical laboratory to demonstrate shifts in antibiotic efficacy driven by polymicrobial interactions. We demonstrate that both polymicrobial synergism (a reduction in antibiotic efficacy in complex bacterial communities) and polymicrobial antagonism (an increase in antibiotic efficacy in the context of a polymicrobial consortium) can be readily observed. Preliminary data suggest that combinatorial treatment strategies can be developed to exploit polymicrobial antagonism to overcome synergistic interactions. We propose to validate this strategy in a murine model of chronic wound infection. Together, these Aims will be used to identify antibiotic treatment strategies that will extend the efficacy of the currently available repertoire of antibiotics.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $349,401 )
2025	2025	TEXAS TECH UNIVERSITY SYSTEM	2500 BROADWAY	LUBBOCK	TX	79409	LUBBOCK	USA	Allergy and Infectious Diseases Research	000	3	7/8/2025	NON-COMPETING CONTINUATION	$349,401
														Subtotal = $349,401

Issue Date FY: 2024 ( Subtotal = $365,565 )
2024	2024	TEXAS TECH UNIVERSITY SYSTEM	2500 BROADWAY	LUBBOCK	TX	79409	LUBBOCK	USA	Allergy and Infectious Diseases Research	000	2	5/29/2024	NON-COMPETING CONTINUATION	$365,565
														Subtotal = $365,565

Issue Date FY: 2023 ( Subtotal = $346,722 )
2023	2023	TEXAS TECH UNIVERSITY SYSTEM	2500 BROADWAY	LUBBOCK	TX	79409	LUBBOCK	USA	Allergy and Infectious Diseases Research	000	1	7/11/2023	NEW	$346,722
														Subtotal = $346,722

Grand Total All Awards = $1,061,688

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections

Award Number: R01AI173686

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/11/2023

PERIOD OF PERFORMANCE END DATE: 06/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer